What is Macro Trials?
Macro Trials is a precision research clinical platform dedicated to revolutionizing clinical trials by seamlessly integrating them into the daily routines of patients and clinicians. The company collaborates with pharmaceutical giants, emerging biotech firms, and contract research organizations (CROs) to expedite the development of novel, safe, and effective therapies. A core tenet of Macro Trials' mission is to champion diversity and inclusion within study populations, ensuring that trial outcomes are representative of real-world demographics. Their technology-forward methodology simplifies trial participation, significantly enhancing patient enrollment and retention rates. By focusing on high-value therapeutics, Macro Trials is poised to redefine the landscape of drug development through pioneering trial designs and sophisticated data capture mechanisms.
How much funding has Macro Trials raised?
Macro Trials has raised a total of $6M across 1 funding round:
Angel/Seed
$6M
Angel/Seed (2023): $6M with participation from MBX Capital, Village Global, INITIATE Ventures, Healthy VC, and Inflict Health
Key Investors in Macro Trials
MBX Capital
MBX Capital is a venture capital firm specializing in healthcare and biotechnology, focusing on early-stage companies that are disrupting conventions in service to public health and inventing in overlooked domains.
Village Global
Village Global VC is an early-stage venture capital firm that supports startups with funding, mentorship, and access to a network of successful entrepreneurs and investors, investing globally in resourceful founders.
INITIATE Ventures
Undisclosed investor participating in the funding round.
What's next for Macro Trials?
The recent major strategic investment signals a pivotal moment for Macro Trials, likely enabling the company to scale its operations, expand its technological capabilities, and deepen its partnerships within the pharmaceutical and biotech sectors. This infusion of capital is expected to accelerate the company's mission to transform clinical trial participation and data collection. Future initiatives may include broader market penetration, further development of their precision research platform, and enhanced focus on diversity and inclusion initiatives within clinical studies. The company's trajectory suggests a continued emphasis on innovation and strategic alliances to drive the future of drug development.
See full Macro Trials company page
